WoundReference improves clinical decisions
 Choose the role that best describes you
Product Type: Human Skin Allografts
Other related brands
NOVADAQ Technologies, Inc. | |
HCPCS : Q4122 (Medicare DME co-payment per billable unit min / max: $0.00 / $0.00)
DermACELL AWM® is a dermal matrix (human skin allograft)
INTENDED USES: Used in the treatment of chronic non-healing wounds such as diabetic foot ulcers.
CLAIMED FEATURES: It is a human acellular dermal matrix (hADM). It is decellularized using Matracell®, a proprietary and patented technology that removes ≥ 97% of donor DNA without compromising the desired biomechanical or biochemical properties of the graft, and allows for rapid cellular infiltration and re-vascularization. Ready to use out of the package and stored at room temperature, eliminating the need for refrigeration and rehydrating processes. As a final step, all Dermacell grafts are terminally sterilized - rendering the graft sterile to medical device-grade standards with a Sterility Assurance Level (SAL) of 10^6.
OPTIONS: Per sqaure centimeter
Wound Reference does not produce, market, re-sell or distribute health care goods or services consumed by, or used on, patients.
Composition: Animal-derived
Composition: Human dermis with/without epidermis
Composition: Human placenta or umbilical cord
Composition: Viable (living) cells
Configuration: Fenestrated/ meshed
Configuration: Flowable
Configuration: Sheet
May apply on full-thickness wounds
May apply over exposed tendon/ bone/ muscle
May apply over infected tissue
Processing: Cryopreserved
Processing: Decellularized or irradiated
Processing: Dehydrated
Processing: Fresh (limited shelf life)
Processing: Hydrated
Processing: Minimally manipulated
Shelf life: Greater than 2 years
Storage: refrigeration needed
Storage: room temp

Application of Skin Substitutes (also known as Cellular and/or Tissue Based Products) to certain wounds may help these wounds heal faster than conventional dressings and conservative treatments. Usually skin substitutes are used if conventional treatment has been tried for at least 30 days and the wound has not healed as quickly as expected. Human skin allografts are a type of skin substitute. They are made of skin donated by human donors that have had intact cells removed or treated to avoid immunologic rejection (a process in which the body of the person receiving the skin substitute kills the cells of the skin substitute).

For Medicare to cover this product, it needs to be ordered and applied by your clinician. A patient cannot purchase it directly from a Durable Medical Equipment (DME) store and receive reimbursement for it.

Important Notice: The product information contained on this page, including the product images and additional product materials, was collected from various supplier sources. All product claims and specifications are those of the product suppliers. Every effort has been made to ensure the accuracy of the product information, however on occasion manufacturers may alter their products or packaging without notice. Wound Reference assumes no liability for inaccuracies or misstatements about products. The properties of a product may change or be inaccurate following the posting or printing of the product information in the document, either in the print or online version. Due to product changes, information listed in this document is subject to change without notice. We recommend that you always read labels, warnings and instructions for use before using a product. Content on this site is for reference purposes and is not intended to be a substitute for professional advice given by a physician or other licensed healthcare professional.
t
-->